You are here

Closed

Reset

NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.

Displaying 18901 - 18910 of 18924 results
  1. : Advanced Tools and Technologies for Cerebrospinal Fluid Shunts STTR

    Release Date: 06-08-2009Open Date: 07-05-2009Due Date: 05-08-2012Close Date: 05-08-2012

    Hydrocephalus is caused by a heterogeneous group of diseases and disorders that can affect individuals of any age, from infants to the elderly. Cerebrospinal fluid (CSF) shunts have been successfully used to treat hydrocephalus for over 50 years and are the most common treatment option for this disorder. In a typical shunt system, a catheter is used to drain the fluid from the brain to a site in t ...

    STTRPhase IDepartment of Health and Human Services
  2. : Advanced Tools and Technologies for Cerebrospinal Fluid Shunts SBIR

    Release Date: 06-08-2009Open Date: 07-05-2009Due Date: 05-08-2012Close Date: 05-08-2012

    Hydrocephalus is caused by a heterogeneous group of diseases and disorders that can affect individuals of any age, from infants to the elderly. Cerebrospinal fluid (CSF) shunts have been successfully used to treat hydrocephalus for over 50 years and are the most common treatment option for this disorder. In a typical shunt system, a catheter is used to drain the fluid from the brain to a site in t ...

    SBIRPhase IDepartment of Health and Human Services
  3. : Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens

    Release Date: 05-19-2009Open Date: 07-05-2009Due Date: 05-08-2012Close Date: 05-08-2012

    Purpose This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), at the National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) propose to develop new technologies and/or improve existing technologies for the detection and evaluation of chemical and biological carcinogens in ...

    SBIRPhase IDepartment of Health and Human Services
  4. : Technologies and Software to Support Integrative Cancer Biology Research

    Release Date: 05-19-2009Open Date: 07-05-2009Due Date: 05-08-2012Close Date: 05-08-2012

    Purpose The goal of this Funding Opportunity Announcement (FOA) is to support the development as commercial products of software, computational/mathematical methods, and laboratory technologies that will facilitate, accelerate, and/or enhance integrative cancer biology research. This FOA encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) t ...

    SBIRPhase IDepartment of Health and Human Services
  5. : Technology for the Detection and Characterization of Low Abundance Proteins, Peptides, or micro RNAs

    Release Date: 05-19-2009Open Date: 07-05-2009Due Date: 05-08-2012Close Date: 05-08-2012

    Purpose This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), and the National Institute of Mental Health (NIMH), at the National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing the development of new technologies or improvements to existing technologies for the i ...

    SBIRPhase IDepartment of Health and Human Services
  6. : Development of In-Vitro Assays to Assess the Potency of Botulinum Neurotoxin Type A

    Release Date: 04-29-2009Open Date: 07-05-2009Due Date: 05-08-2012Close Date: 05-08-2012

    Clostridium botulinum is an anaerobic bacterium that produces a neurotoxin thought to be the most lethal substance known (on a per molecule or per weight basis). Strains of C. botulinum have been identified that produce 7 different types of this neurotoxin, designated as types A through G. The toxin is synthesized as a single polypeptide of approximately 150 kD. Selective proteolysis is important ...

    STTRPhase IDepartment of Health and Human Services
  7. : Development of In-Vitro Assays to Assess the Potency of Botulinum Neurotoxin Type A

    Release Date: 04-29-2009Open Date: 07-05-2009Due Date: 05-08-2012Close Date: 05-08-2012

    Clostridium botulinum is an anaerobic bacterium that produces a neurotoxin thought to be the most lethal substance known (on a per molecule or per weight basis). Strains of C. botulinum have been identified that produce 7 different types of this neurotoxin, designated as types A through G. The toxin is synthesized as a single polypeptide of approximately 150 kD. Selective proteolysis is important ...

    SBIRPhase IDepartment of Health and Human Services
  8. : Multiplex Assay Development for Arthritis and Musculoskeletal and Skin Diseases

    Release Date: 04-06-2009Open Date: 07-05-2009Due Date: 09-08-2012Close Date: 09-08-2012

    Background: The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is interested in SBIR projects to develop multiplex assay methodologies for candidate biomarkers of musculoskeletal, rheumatic and skin diseases. The assay technologies are intended to enable accurate quantitative measurement of multiple candidate biomarkers in small volumes of blood or other body flui ...

    SBIRPhase IDepartment of Health and Human Services
  9. : Tools to Mitigate and Understand the Mental Health Effects of National Disasters

    Release Date: 03-03-2009Open Date: 03-05-2009Due Date: 01-08-2012Close Date: 01-08-2012

    Background The physical impact of Hurricane Katrina occurred over hours and days. The mental health effects of this large-scale, traumatic event may be fully evident only over weeks, months, years, and, perhaps, generations. The types of trauma from such events are many, diverse, and complex. The affected populations, including both direct victims and those secondarily involved (e.g., first resp ...

    SBIRPhase IDepartment of Health and Human Services
  10. : Manufacturing Processes of Medical, Dental, and Biological Technologies

    Release Date: 02-26-2009Open Date: 03-05-2009Due Date: 01-08-2012Close Date: 01-08-2012

    On February 26, 2004, Executive Order 13329 (http://a257.g.akamaitech.net/7/257/2422/14mar20010800/edocket.access.gpo.gov/2004/pdf/04-4436.pdf) was signed by President George W. Bush requiring SBIR/STTR agencies, to the extent permitted by law and in a manner consistent with the mission of the Department, to give high priority within the SBIR and STTR programs to manufacturing-related research and ...

    SBIRPhase IDepartment of Health and Human Services
US Flag An Official Website of the United States Government